Nifty Pharma index may correct in near-term, downside target seen at 12,700

The Nifty Pharma Index is currently trading at a CMP of 12,976.80. The index is expected to undergo a consolidation phase with a negative bias

market, stocks, stock market trading, stock market
Ravi Nathani Mumbai
2 min read Last Updated : Jun 15 2023 | 7:30 AM IST
Nifty Realty Index
The Nifty Realty Index is currently trading at a CMP of 522.15. The next resistance levels to watch out for are around 538 and 560, where the index may face selling pressure. The recommended trading strategy in this scenario would be to buy on dips. This means looking for opportunities to enter the market at lower prices, taking advantage of temporary pullbacks or corrections within the overall uptrend. Support levels for the index are expected around 505 and 495, where there couldbe a bounce back due to buying interest. 

Nifty Pharma Index
The Nifty Pharma Index is currently trading at a CMP of 12,976.80. The index is expected to undergo a consolidation phase with a negative bias, as indicated by the correction phase on the daily charts. The consolidation range for the index is between 13,100 and 12,840. A close above or below this range would add a trigger for further price movement in the corresponding direction. It is important to monitor the index's price action in relation to these levels for potential trading opportunities. Various technical indicators, including RSI, MACD, and Stochastic, are showing negative divergence. This suggests that the index may experience a decline in price or a correction in the near term. Considering the negative bias and the indications from technical indicators, the recommended trading strategy would be to sell on rallies or book profits at the current market price. Traders can target potential downside levels around 12,700 and 12,575.

================================
Disclaimer: Ravi Nathani is an independent technical analyst. Views expressed are personal. He does not hold any positions in the Indices mentioned above.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Stock callsMarketsNifty Realty IndexNifty PharmaMarket OutlookTrading strategies

First Published: Jun 15 2023 | 7:30 AM IST

Next Story